Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11874817 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Two Different Dosages of Nebulized Steroid Versus Parenteral Steroid in the Management of COPD Exacerbations
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Budesonide 4 mg;   Drug: Budesonide 8 mg;   Drug: Metil prednisolone

Indicates status has not been verified in more than two years